Fig. 1: Upregulation of S100A4 expression in NSCLC tissues.
From: S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition
Tissue microarray from 120 lung cancer patients was stained with anti-S100A4. a Representative S100A4 staining is shown at ×200 (upper) and ×400 magnifications (lower). Scale bar, 50 μm. b Percent of the cases expressing S100A4 in carcinoma tissues. c Percent of S100A4 negative, low and high expression in different tumor grades. d Average tumor size in NSCLC patients with different S100A4 protein levels
